Tolmar In the News
Discover the latest in Tolmar’s mission towards
a healthier world.
a healthier world.
We’re proud of the work we do to bring scientific and clinical advancements to the world of pharmaceuticals. Check out the latest on how Tolmar is making a difference in our communities.
Tolmar Publishes FENSOLVI® (leuprolide acetate) for Injectable Suspension Safety and Efficacy Data in Journal of Clinical Endocrinology and Metabolism
Tolmar Affirms Supply of FENSOLVI® (leuprolide acetate) for Pediatric Patients with Central Precocious Puberty
Tolmar Affirms Full Supply of Eligard® (Leuprolide Acetate) for Injectable Suspension for the Palliative Management of Advanced Prostate Cancer
FDA Approves FENSOLVI® (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty
ELIGARD (leuprolide acetate) for Injectable Suspension Continues Growth Momentum With Favorable Formulary Positions – Placement with EnvisionRx Fuels Market-Leading Growth
Articles & Announcements
We keep ourselves at the forefront of treatment and therapy advancements. Explore our innovative ideas and insights into the world of pharmaceuticals.